FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/11/2017
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Tipo de processo
Eventos registrados
Atualização mais recente
Classificação
Tipo de marca
Classes Nice
Data de depósito
Data de registro
Data de expiração
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
Última transação
Escritório responsável
Código da situação
Cadastro oficial
Código do desenho
Tipo de titular
Localização do titular
Examinador
Unidade examinadora
Localização atual
Titulares
Representantes
RIVOPHARM SA
Classes Nice
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparations, both prescription and over-the-counter, namely pharmaceutical preparations for peptic ulcer and gastroesophageal reflux disease (GORD), propulsives, intestinal anti-infectives, intestinal anti-inflammatory agents, oral pharmaceutical preparations for lowering blood glucose, Vitamin A and D, mixed vitamin preparations consisting of vitamins A and D, vitamin and mineral preparations for medical use, vitamin C in the nature of ascorbic acid, mixed vitamin preparations consisting partially of Vitamin C, calcium supplements, mineral supplements, anti-thrombotic agents, intravenous solutions, cardiac glycosides, class I and class III anti-arrhythmics, pharmaceutical preparations for cardiac stimulation excluding cardiac glycosides, Vasodilators used in the treatment of cardiac diseases, anti-adrenergic agents, pharmaceutical preparations for acting on arteriolar smooth muscle, Beta blocking agents, Selective calcium channel blockers, pharmaceutical preparations in the nature of Angiotensin Converting Enzyme inhibitors, pharmaceutical preparations in the nature of Angiotensin Converting Enzyme inhibitors combined with other pharmaceutical preparations, anti-fungals for systemic use, anti-infectives and antiseptics, excluding those combined with corticosteroids, oxytocics, plain corticosteroids for systemic use, thyroid preparations, anti-thyroid preparations, tetracyclines preparations, macrolides, lincosamides and streptogramins, aminoglycoside antibacterials, quinolone antibacterials, antimycotics for systemic use, direct acting antivirals, immune sera, bacterial vaccines, alkylating agents, anti-metabolites, plant alkaloids, cytotoxic antibiotics, hormone antagonists and related agents, namely anti-estrogens, anti-androgens and enzyme inhibitors, immunosuppressive agents, anti-inflammatory and anti-rheumatic preparations, non-steroids in the nature of butylpyrazolidines, acetic acid derivatives, oxicams, propionic acid derivatives, fenamates, Coxibs, muscle relaxants, peripherally acting agents in the nature of curare alkaloids and choline derivatives, antigout preparations, analgesics and antipyretics preparations, anti-migraine preparations, anti-epileptic preparations, anti-cholinergic agents, dopaminergic agents, anti-psychotics, anxiolytics, hypnotics and sedatives, antidepressants, parasympathomimetics, agents for use against amoebiasis and other protozoal diseases, anti-malarial preparation, adrenergics, inhalant anesthetics, adrenergics for systemic use, antihistamines for systemic use, diuretic agents
Histórico de despachos e eventos da marca no USPTO.
34 publicações encontradas
FINAL DECISION TRANSACTION PROCESSED BY IB
03/11/2017
NOTIFICATION PROCESSED BY IB
13/10/2017
REFUSAL PROCESSED BY IB
09/12/2016
TOTAL INVALIDATION PROCESSED BY THE IB
24/07/2015
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
06/07/2015
INVALIDATION PROCESSED
06/07/2015
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
27/02/2015
CANCELLED SECTION 71
27/06/2014
FINAL DECISION TRANSACTION PROCESSED BY IB
05/06/2009
FINAL DISPOSITION NOTICE SENT TO IB
27/02/2008
FINAL DISPOSITION PROCESSED
27/02/2008
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
20/02/2008
REGISTERED-PRINCIPAL REGISTER
20/11/2007
PUBLISHED FOR OPPOSITION
04/09/2007
NOTICE OF PUBLICATION
15/08/2007
LAW OFFICE PUBLICATION REVIEW COMPLETED
29/05/2007
ASSIGNED TO LIE
29/05/2007
APPROVED FOR PUB - PRINCIPAL REGISTER
10/05/2007
TEAS/EMAIL CORRESPONDENCE ENTERED
18/04/2007
CORRESPONDENCE RECEIVED IN LAW OFFICE
18/04/2007
TEAS RESPONSE TO OFFICE ACTION RECEIVED
18/04/2007
NON-FINAL ACTION MAILED
06/02/2007
NON-FINAL ACTION WRITTEN
05/02/2007
TEAS/EMAIL CORRESPONDENCE ENTERED
15/01/2007
CORRESPONDENCE RECEIVED IN LAW OFFICE
15/01/2007
TEAS RESPONSE TO OFFICE ACTION RECEIVED
15/01/2007
REFUSAL PROCESSED BY IB
05/01/2007
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
18/12/2006
REFUSAL PROCESSED BY MPU
18/12/2006
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
14/12/2006
NON-FINAL ACTION WRITTEN
13/12/2006
ASSIGNED TO EXAMINER
06/12/2006
NEW APPLICATION ENTERED
08/09/2006
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/09/2006
Proteção contínua da sua marca
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.